Upcoming Events
- Personalized Cancer Vaccine Summit
December 3-5, 2024
News
- Cancer Vaccines: New Targeting Strategies, Brighter Prospects: Genetic Engineering & Biotechnology News, August 1, 2024
- AACR: Cancer Vaccines Get a Reintroduction as Readouts Support ‘Path Forward’ for the Tech: Fierce Biotech, April 10, 2024
- AACR 2024: What Cancer Researchers are Talking About: BioSpace, April 10, 2024
- Geneos Announces Positive Data in GT-30 Clinical Trial: Vaccine Nation, April 9, 2024
- AACR Roundup: BioCentury, April 9, 2024
- US Researchers Reveal Positive Results of Personalised Vaccine for Liver Cancer: PharmaTimes Online, April 9, 2024
- AACR 2024: Geneos Therapeutics’ Vaccine Outperforms Liver Cancer Immunotherapies: GenEdge, April 9, 2024
- Can a Personalized Antitumor Vaccine Plus Pembrolizumab Improve Outcomes in Hepatocellular Carcinoma?: The ASCO Post, April 8, 2024
- Health News Roundup: Devdiscourse, April 8, 2024
- Geneos’ Vaccine Shows Promise in Hepatocellular Carcinoma: Clinical Trials Arena, April 8, 2024
- Geneos Cancer Vaccine Shrinks Liver Tumors In Small Trial: Reuters, April 7, 2024
- Geneos Therapeutics’ Cancer Vaccine Shows Potential for Shrinking ‘Difficult’ Tumors: Precision Medicine Online, November 17, 2023
- Geneos: DNA-based, Personalized Cancer Vaccines: BioCentury, April 17, 2023